AI-generated summary
The authors report a case series of 14 patients with 20 lesions of Old World cutaneous leishmaniasis treated weekly with a 1540 nm erbium glass fractional laser. Of 12 lesions assessed, 91.7% improved at 12 weeks, and no recurrences were seen at 6- and 12-month follow-up. The authors suggest the laser may be an alternative for localized cases.
- Participants
- 14
- Who or what was studied
- Fourteen patients (10 females) with 20 lesions of Old World cutaneous leishmaniasis
- Wavelengths
- 1540 nm
- Limits stated in the abstract
- The study is a small case series, and only 12 of the 20 lesions were available for assessment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1540 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.